3D nuclear telomeric signatures define circulating tumor cells (CTCs) and characterize CTC subpopulations in intermediate risk prostate cancer patients

ScreenCell.com Published on April 25th, 2014

Awe, et.al. AACR April2014_pdf


Need more information? PleaseĀ Contact us